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Abstract 
To investigate the role of nerve growth factor (NGF) in the development of hypertensive 
renal vascular remodeling, antiserum against NGF (anti-NGF) or vehicle was injected at 
3 weeks of age in spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats 
(n=9 for each treatment in each strain). Flow-pressure (F-P) and pressure-glomerular 
filtration rate (P-GFR) relationships at vasodilated perfused kidneys were determined at 
10 weeks of age. In the vehicle rats, blood pressure, renal noradrenaline content, the 
gradient of F-P (minimal vascular resistance at pre- and post-glomerular vasculature) 
and the X-intercept of P-GFR (preglomerular：postglomerular vascular resistance ratio) 
were greater in SHR than in WKY rats, although the gradient of P-GFR (glomerular 
filtration capacity) did not differ significantly between the strains. Blood pressure and 
renal noradrenaline content were lower in SHR receiving anti-NGF than in SHR 
receiving vehicle, although such difference was not observed in WKY rats. The gradient 
of F-P was less but the gradient of P-GFR was greater in SHR receiving anti-NGF 
compared with SHR receiving vehicle, although the similar differences did not occur in 
WKY rats. Blood pressure and renal noradrenaline content remained greater in SHR 
treated with anti-NGF compared with WKY rats treated with vehicle; however, the 
gradient of F-P did not differ significantly between them. Contrary, anti-NGF did not 
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affect the X-intercept of P-GFR in either strain. In conclusion, NGF could contribute to 
the genesis of renal vascular remodeling, at least in part, through modification of renal 
sympathetic activity and blood pressure in SHR. 
Key words: nerve growth factor, immunosympathectomy, renal vascular remodeling, 
spontaneously hypertensive rat, vasodilated perfused kidney 
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Introduction  
In systemic hypertension, it is well known that resistance vessels become 
thicker or encroach into the lumen in kidneys as well as in other organs [1, 2]. In 
spontaneously hypertensive rats (SHR), a model of human essential hypertension, such 
renal vascular changes occur mainly in the preglomerular vessels at the prehypertensive 
or early hypertensive stage [3-8]. This structural remodeling of the renal vasculature can 
promote hypertension by increasing renal vascular resistance and reducing both 
glomerular filtration and sodium excretion in SHR [8]. Because the sympathetic 
nervous system controls vascular growth and structures [9, 10] and its activity is 
enhanced in SHR [11, 12], the increase in renal sympathetic nerve activity is related 
with the genesis of renal vascular remodeling in SHR [7]. 
Nerve growth factor (NGF) is a protein required for development and 
maintenance of the sympathetic neurons [13, 14]. NGF is synthesized in organs 
innervated by sympathetic nerves, incorporated by sympathetic nerve endings and 
transported through axons to neural cell bodies [13, 14]. In most tissues including 
kidneys, tissue levels of NGF protein correlate closely with the density of sympathetic 
innervations and sympathetic nerve activity [15-17]. Therefore, in hypertension, renal 
synthesis of NGF can modulate renal sympathetic neural activity, thereby affecting both 
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the renal vasculature and blood pressure. This thesis is supported by the observation that 
NGF mRNA and protein increased in kidneys as well as mesenteric arteries of SHR [15, 
18-20]. Furthermore, an administration of antiserum against NGF (anti-NGF) attenuated 
or prevented the development of vascular hypertrophy and hypertension concomitantly 
with reducing sympathetic neural innervation and activity in the prehypertensive SHR 
[21-25]. Conversely, NGF treatment of normotensive Wistar-Kyoto (WKY) rats induced 
vascular hyperinnervation and increased vascular wall thickness, which are 
characteristics of SHR [26]. However, it is still unknown how an overproduction of 
NGF can lead to vascular remodeling via its influences on sympathetic neural 
innervation and activity in the kidneys of SHR.  
In the present study, therefore, the following experiments were performed to 
explore that higher level of renal NGF would cause renal vascular remodeling and high 
blood pressure via its effect on renal sympathetic nerve activity in SHR using WKY rats 
as a normotensive control. Firstly, the capability of NGF synthesis was compared 
between the two strains in several organs at 3 weeks of age. Secondly, in both strains, 
renal vascular structures and blood pressure as well as renal sympathetic neural activity 
were investigated following the immunosympathectomy using anti-NGF at the pubertal 
stage.  
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Results  
Experiment 1: Expression of NGF mRNA in organs of 3-week-old SHR and WKY 
rats 
Expression of NGF mRNA was significantly elevated in the kidney, left 
ventricle (not in the right ventricle) and submandibular glands of SHR compared with 
those of WKY rats at 3 weeks of age (Table 1). Especially, renal expression of NGF 
mRNA was 3.9 times higher in SHR than in WKY rats.  
Experiment 2: Effects of immunosympathectomy on the renal vasculature, renal 
catecholamine content and blood pressure 
In the rats treated with vehicle, systolic blood pressure was significantly higher 
in SHR than in WKY rats (P< 0.001) at 9 weeks of age, although pulse rate did not 
differ significantly between the two strains (P= 0.68, Table 2). At 10 weeks of age, renal 
noradrenaline content, left ventricular weight and right kidney wet weight were greater 
in SHR than in WKY rats (P< 0.001, P< 0.001 and P= 0.04, respectively), whereas 
body weight was slightly less in SHR than in WKY rats (P= 0.011).  
 Systolic blood pressure, pulse rate and renal noradrenaline content did not 
differ significantly between WKY rats treated with anti-NGF and with vehicle (P= 0.12, 
0.081 and 0.25, respectively). Contrary, systolic blood pressure and renal noradrenaline 
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content were less in SHR treated with anti-NGF than in SHR treated with vehicle (P= 
0.018 and 0.006, respectively), although pulse rate did not differ significantly between 
the two groups (P= 0.78). However, the effects of anti-NGF on systolic blood pressure 
and renal noradrenaline content did not differ significantly between the two strains (P= 
0.40 and 0.11 for strain × treatment interaction, respectively). Additionally, both 
parameters remained greater in SHR treated with anti-NGF compared with WKY rats 
treated with vehicle (P< 0.001 for each).  
There was no significant difference in body weight, pulse rate and organ 
weights between the rats treated with anti-NGF and with vehicle in either strain.  
Haemodynamic findings in vasodilated kidneys at 10 weeks of age 
A linear relationship was seen between perfusion flow and arterial distending 
pressure within each individual perfusion experiment, with Pearson correlation 
coefficients (r2) ranging from 0.96 to 0.99 (Figure1). A linear relationship was also seen 
between arterial distending pressure and GFR within each individual experiment, with 
r2 ranging from 0.96 to 0.99 (Figure 2). 
In the rats treated with vehicle, the gradient of the flow-pressure relationship 
was significantly greater in SHR than in WKY rats at 10 weeks of age (P< 0.001, Table 
3). In contrast, the X intercept of the pressure-GFR relationship was significantly higher 
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in SHR than in WKY rats (P< 0.001), although the gradient of the pressure-GFR 
relationship did not differ significantly between the two strains (P= 0.15). These results 
indicate that minimal vascular resistance was elevated with an increase in 
preglomerular：postglomerular vascular resistance ratio in the kidneys of SHR, although 
glomerular filtration capacity was normal.  
The gradient of the flow-pressure relationship, and the X intercept and the 
gradient of the pressure-GFR relationship did not differ significantly between WKY rats 
treated with anti-NGF and with vehicle (Table 3, P= 0.19, 0.28 and 0.30, respectively). 
Conversely, the gradient of the flow-pressure relationship was less in SHR treated with 
anti-NGF than in SHR treated with vehicle (Table 3, P< 0.001), although the X intercept 
of the pressure-GFR relationship did not differ significantly between the two groups 
(Table 3, P= 0.23). The gradient of pressure-GFR relationships was also greater in SHR 
treated with anti-NGF than in SHR treated with vehicle (Table 3, P= 0.003). 
Additionally, the effects of anti-NGF on minimal renal vascular change and glomerular 
filtration capacity were significantly different between the two strains (P= 0.009 and 
0.036 for strain × treatment interaction, respectively). As a result, there were no 
significant differences in minimal vascular resistance between SHR treated with 
anti-NGF and WKY rats treated with vehicle (P= 0.47), whereas glomerular filtration 
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capacity was greater in SHR treated with anti-NGF than in WKY rats treated with 
vehicle (P= 0.004).  
Histological findings in the vasodilated kidneys at 10 weeks of age 
In the rats treated with vehicle, the internal luminal area of the interlobular 
arteries (one of the preglomerular resistance vessels) was significantly smaller in SHR 
than in WKY rats at 10 weeks of age (P= 0.010) (Figure 3, Table 4). The wall 
cross-sectional area of these vessels was significantly greater in SHR than in WKY rats 
(P< 0.001). As a result, the wall：lumen ratio was significantly greater in SHR compared 
with WKY rats (P< 0.001). Glomerular tuft area was also greater in SHR than in WKY 
rats at both superficial and juxtamedullary nephrons (P< 0.001 for each). There were no 
increases in mesangial matrix and no glomerular sclerosis in either strain.  
The internal luminal area and wall cross-sectional area of the interlobular 
arteries did not differ significantly between WKY rats treated with anti-NGF and with 
vehicle (P= 0.22 and 0.97, respectively) (Figure 3, Table 4). Contrary, the internal 
luminal area was greater but the wall cross-sectional area was less in SHR treated with 
anti-NGF compared with SHR treated with vehicle (P= 0.001 and 0.033, respectively). 
As a result, the wall：lumen ratio of the interlobular arteries was less in SHR treated 
with anti-NGF than in SHR treated with vehicle (P< 0.001), although it did not differ 
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significantly between the two treatment groups in WKY rats (P= 0.23). Additionally, the 
effects of anti-NGF on internal luminal area and wall：lumen ratio were significantly 
different between both strains (P< 0.001 in each for strain × treatment interaction). 
These two parameters also did not differ significantly between SHR treated with 
anti-NGF and WKY rats treated with vehicle (P= 0.12 and 0.19, respectively) (Table 4). 
On the other hand, anti-NGF did not affect glomerular tuft area and induce any 
morphological changes suggestive of glomerular damages in either strain. 
Discussion 
To the best of our knowledge, the present study was the first to ascertain the 
effects of immunosympathectomy using anti-NGF on renal vascular structural changes 
in hypertensive animals. The major findings of the present study are as follows. First, 
renal expression of NGF mRNA was enhanced in SHR compared with WKY rats at the 
pubertal period, i.e., 3 weeks of age. In the kidneys of young SHR aged 10 weeks, 
vascular narrowing occurred predominantly at the preglomerular resistance vessels with 
vascular hypertrophy, a finding consistent with hypertrophic inward remodeling, despite 
there being no abnormality in the whole kidney filtration capacity. These findings in 
SHR are consistent with those in the previous reports [4-8]. Secondly, in SHR, the 
single administration of anti-NGF at 3 weeks of age attenuated hypertension as well as 
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elevation in renal noradrenaline content 7 weeks later, but did not prevent these 
completely. Conversely, the anti-NGF treatment did not affect blood pressure and renal 
noradrenaline content in WKY rats. Thirdly, most importantly, the development of renal 
vascular structural alterations was affected by the anti-NGF treatment at the pubertal 
stage in SHR. That is, in the kidneys of SHR, the anti-NGF treatment prevented the 
development of vascular narrowing in the whole renal resistance vessels (i.e., pre- and 
post-glomerular vasculature), although it did not influence the preglomerular : 
postglomerular vascular resistance ratio. The anti-NGF treatment also enhanced 
glomerular filtration capacity against pressure in SHR. Furthermore, the influences of 
anti-NGF treatment on renal vascular structures were specific for SHR, because the 
anti-NGF treatment did not affect any parameters for renovascular structures in WKY 
rats.  
The possible mechanisms of renal structural responses to the anti-NGF treatment 
in SHR  
It is well-known that an overactivation of sympathetic nervous system occurs 
prior to the onset of hypertension [11, 12]. Because the sympathetic nervous system 
exerts a hypertrophic effect on the cardiovascular structures [9, 10], enhanced 
sympathetic nerve activity or sympathetic hyperinnervation can induce cardiovascular 
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structural remodeling such as vascular or cardiac hypertrophy [2, 10, 12]. Such 
cardiovascular structural remodeling can amplify responses of the vessels and heart to 
vasoconstrictor stimuli, leading to increases in total peripheral resistance and cardiac 
output [1, 2]. Therefore, cardiovascular structural remodeling secondary to increased 
sympathetic neural activity has long been regarded as one of the factors to promote and 
maintain hypertension [1, 2, 8, 10]. Furthermore, vascular overproduction of NGF 
might be responsible for the enhanced vascular sympathetic neural activity that is 
implicated in the vascular remodeling of hypertensive animals [12, 15, 21-24]. However, 
in SHR, the relationships between NGF and cardiovascular structures were evaluated 
mainly in the mesenteric arteries, heart and hindquarter vascular beds [21-25], but not in 
renal vessels and glomeruli.  
In the present study, the anti-NGF treatment inhibited the development of 
vascular narrowing at the whole renal resistance vessels in the kidneys of SHR and this 
vascular widening appears to have occurred in the preglomerular and postglomerular 
resistance vessels to a similar degree. This renal haemodynamic alteration was 
characterised histologically by the prevention of the development of hypertrophic 
inward remodeling at the interlobular arteries in the kidneys of SHR. The anti-NGF 
treatment also enhanced glomerular filtration against pressure without any 
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morphological changes in glomeruli in the kidneys of SHR. Thus, in SHR, the single 
administration of anti-NGF at the pubertal period regressed the renal vascular 
remodeling, although it did not normalise blood pressure and renal noradrenaline 
content. However, the previous reports demonstrated that anti-NGF alone could not 
prevent the development of cardiac hypertrophy and vascular remodeling in mesenteric 
arteries and hindquarter vascular beds in SHR [23-25]. Accordingly, in SHR, renal 
vasculature appeared to exhibit hyper-responsiveness to the anti-NGF treatment 
compared with heart and other vascular beds. Indeed, in the present study, anti-NGF did 
not reduce left ventricular weight in SHR. Although it seems hard to explain the 
differences of responsiveness to anti-NGF between renal vasculature and other vascular 
beds, renal vasculature might be highly sensitive to the inhibition of sympathetic neural 
activity induced by anti-NGF in SHR. Alternatively, because NGF has also direct 
proliferative actions on vascular smooth muscle cells, endothelial cells and 
inflammatory cells [27-29], the renal vascular structures might be strongly affected by 
the additive inhibition of anti-NGF on the growth of these non-neuronal cells in SHR. 
Of course, reduced systemic pressure and/or inhibited renin angiotensin aldosterone 
system secondary to sympathetic inhibition should play important roles in the regression 
of renal vascular remodeling following the anti-NGF treatment in SHR [30, 31].  
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The influences of the anti-NGF treatment on blood pressure and renal 
noradrenaline content in SHR 
NGF synthesis was enhanced in the organs of SHR compared with those in 
WKY rats at the pubertal stage. This phenomenon is supported by the previous reports 
demonstrating that in SHR, cardiac content of NGF peptide is higher at 18-24 days  
[18] and renal NGF m-RNA is enhanced at 3 and 10 weeks of age [20]. The difference 
of NGF synthesis in organs between the two strains seems to be due to the genetic 
differences in NGF gene or NGF gene transcription, but not in physiological influence 
of blood pressure, because it occurred prior to the onset of hypertension [20] .   
In the present study, the single administration of anti-NGF was performed for 
immunosympathectomy at 3 weeks of age at which the enhanced synthesis of NGF 
occurred in organs of SHR. However, the sympathectomy using anti-NGF alone was not 
so powerful to normalise renal noradrenaline content in SHR. The similar incomplete 
sympathectomy was reported previously in SHR treated with anti-NGF alone [23-25]. 
Because the immunosympathectomy using anti-NGF alone spares the 
catecholamine-producing cells of the adrenal medulla, reflex-induced secretion of 
catecholamines from adrenal glands might occur in response to the removal of 
sympathetic neural support [10, 23]. Alternatively, re-innervation to the kidney might 
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occur following the sympathectomy in SHR [10, 23]. These two phenomena secondary 
to the immunosympathectomy using anti-NGF alone could reduce the efficacy of 
immunosympathectomy on renal sympathetic neural activity. Furthermore, anti-NGF 
might also affect baroreflex function in the central nervous system to alter sympathetic 
outflow to the kidneys [32], because neurotrophic factors including NGF and their 
receptors are highly expressed in the brain stem [13, 33]. Indeed, an injection of brain 
derived neurotrophic factor (one of the neurotrophic factors) into the nucleus tractus 
solitaries, the area critical for baroreflex function, can increase arterial pressure in rats 
[34]. Therefore, the inhibitory effects of anti-NGF on renal sympathetic nerve activity 
could be mediated by the influences of anti-NGF on pre-ganglionic neurons as well as 
post-ganglionic neurons. 
Implications of renal structural alterations following the anti-NGF treatment in 
SHR  
Taking into account the amplification of responses to vasoactive stimuli in 
vascular remodeling [1, 2, 30, 31], the following sequence of events may ensue in the 
kidney of SHR. Hypertrophic inward remodeling occurred in the preglomerular 
resistance vessels without changes in glomerular filtration capability in the kidneys of 
young SHR. These vascular structural changes could enhance renal vasoconstriction 
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predominantly in the preglomerular vessels and reduce glomerular filtration, thereby 
decreasing renal excretory capability, even if the neurohumoral influences on the 
kidneys remain to be unchanged [1, 2, 8]. Consequently, systemic arterial pressure 
would be expected to increase in a way that offsets the reduced renal excretory function.  
The anti-NGF treatment significantly affected the above mentioned changes in 
the renal vascular tree in SHR. That is, anti-NGF dilated averaged vascular lumen at the 
whole renal resistance vessels and enhanced glomerular filtration capability against 
pressure. These effects of anti-NGF on renal vascular remodeling could reduce the 
amplifier characteristics of vessels in the kidneys of SHR, thereby improving the 
reduction in renal excretory function [1, 2, 8]. However, theses expected effects of 
anti-NGF on renal excretory function could be depressed possibly by the residual 
elevation in preglomerular：postglomerular vascular resistance ratio in the renal 
resistance vessels of SHR. Therefore, the total effects of anti-NGF on renal vasculature 
could not be sufficient enough to normalise renal excretory function in SHR. Of course, 
to confirm this hypothesis, further studies are needed to explore the changes in other 
factors, including vascular reactivity and endothelial function, that could confound and 
modify such intrarenal haemodynamics [30, 31]. Actually, in SHR treated with 
anti-NGF, the residual elevation in renal sympathetic neural activity could affect the 
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renal pressure-natriuresis relationship, thereby disturbing the normalisation of renal 
excretory function [32].  
Methodological considerations  
The methodological aspects of the present study deserve comments. First, 
single administration of anti-NGF at the pubertal period was used to perform 
immunosympathectomy in SHR. Brock et al demonstrated in SHR, that an 
intraperitoneal injection of a single dose (33 µL・g of body weight-1) of antiserum to 
NGF on the 19 or 24 postnatal day inhibited the later developments of hypertension as 
well as increase in sympathetic neural activity at 12 to 15 weeks of age [21]. In the 
present study, therefore, we specifically selected the similar route, dosage and age of the 
treatment with anti-NGF as proposed by Brock [21], although several reports did not 
support the effectiveness of anti-NGF alone on immunosympathectomy [23-25]. Second, 
renal vascular structure was assessed haemodynamically using an in vitro, maximally 
dilated whole-kidney perfusion technique, as in previous studies [6, 7, 35]. In contrast 
with histological analysis, this physiological technique is accurate and sensitive enough 
to detect subtle changes in lumen diameter in resistance vessels, as follows [2, 8]. It can 
determine vascular luminal changes at the whole renal resistance vessels (i.e., pre- and 
post-glomerular vasculature). It can also determine whether the luminal changes are 
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confined to either the pre- or post-glomerular circulation. However, we cannot 
determine whether luminal changes at the preglomerular circulation occurred in the 
afferent arteriole, larger upstream vessels or both, or whether luminal changes were 
located in the cortical or medullary vessels. Third, histological evaluation of tyrosine 
hydroxylase (a rate-limiting enzyme to synthesise cathecolamines), histological staining 
of growth-associated factor 43 and neurofilament (markers for sympathetic innervation) 
or renal noradrenaline spillover could be suitable for the precise evaluations of renal 
sympathetic innervation and activity and support the present data concerning renal 
catecholamine content [12, 24, 36-38]. Fourth, anti-NGF treatment seemed to affect 
both afferent and efferent renal nerve, because NGF regulates innervation and neural 
activity in both nerves [13, 33]. However, it could not be elucidated in the present study 
whether anti-NGF affected either efferent, afferent or both. Fifth, most importantly, the 
cause and effect relationship between overproduction of renal NGF and vascular 
remodeling could not be deduced only from the present data. It is needed for the definite 
conclusion on this regard to examine whether the administration of NGF to WKY rats at 
3 weeks of age can induce the increase in sympathetic innervation and vascular 
remodeling characteristic to the kidneys of SHR.  
Although the study was limited for these reasons, it clearly demonstrated that 
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anti-NGF prevented the later development of vascular narrowing in the whole renal 
resistance vessels without normalisation of blood pressure and renal sympathetic 
activity in SHR. These results suggest that in the kidneys of SHR, NGF could be 
associated with the genesis of vascular remodeling, partially mediated by its 
modification of sympathetic activity and blood pressure.  
Methods 
Animals 
The study design and experimental protocols were in accordance with our 
institutional guidelines for animal research and the present study was approved by the 
Animal Experiment Committee of the University of Toyama. Three-week-old male SHR 
and WKY rats from the Izumo strain were purchased (n=24 in each strain). All rats were 
fed on a normal salt (0.3 % NaCl) diet and housed in a room maintained at constant 
temperature (23-25 °C) with a 12-hour light/dark cycle throughout the study period. 
Experiment 1: NGF mRNA levels in organs of 3-week-old SHR and WKY rats 
In three-week-old SHR and WKY rats (n=6 in each strain), kidneys, heart and 
submandibular glands were perfused by diethyl pyrocarbonate (DEPC) under 
anaesthesia and then removed. The extract of total RNA was extracted by 
homogenisation of the removed organs with TRIsure (Bioline, London, UK) according 
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to the manufacture’s instruction. The extracts of total RNA (300 ng) was mixed with 25 
pmol oligo (dT) primer, 50 pmol random 6 mers, Prime Script® Buffer and Prime 
Script® RT Enzyme Mix (TaKaRa, Shiga, Japan) and subsequently cDNA was 
synthesised by reverse transcription polymerase chain reaction (RT-PCR). The reverse 
transcription was run at 37°C for 30 min. Real-time PCR was performed with Power 
SYBR® Green PCR Master Mix, using a TaKaRa Dice Real Time System TP800 
(TaKaRa, Shiga, Japan). The replication was carried out with the following cycling 
protocol (5 min of heat activation of the enzyme at 95℃, 45 cycles of denaturation at 
95℃ for 20 s, annealing at 59 ℃ for 20 s, and extension at 72 ℃ for 20 s). Primer 
sequences used for PCR were as follows: 5`- ACCTCTTCGGACACTCTGGA -3` and 
5`- GTCCGTGGCTGTGGTCTTAT -3` as rat NGF primers (up and down) and 
5`-CTCAGTGCCTCACTCCATCA-3` and 5`-CTTCCTTTGCTTCGACCTTG-3` as rat 
36B4 primers (up and down). Finally, the relative amount of each transcript was 
normalised by the expression of ribosomal protein, large, P0 (36B4) and expressed 
using ΔΔCt method [39, 40]. 
Experiment 2: Effects of immunosympathectomy on the renal vasculature, renal 
catecholamine content and blood pressure  
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According to the method of immunosympathectomy proposed by Brock et al 
[21], the animals were randomly assigned to receive an intraperitoneal injection with a 
single dose (40 µL・g of body weight-1) of either rabbit antiserum against the β-subunit 
of NGF (anti-NGF; Cedarlane Laboratories Limited, Hornby, Ontario, Canada) or rabbit 
serum at 3 weeks of age (n=9 of each treatment in each strain). At 9 weeks of age, 
systolic blood pressure was measured in the conscious state by the tail-cuff method. 
Prior to the measurement of blood pressure, rats had been trained to become accustomed 
to the equipment. At 10 weeks of age, each rat was subjected to the following 
experiments using perfused kidneys.  
In vitro measurements in maximally vasodilated, perfused kidneys  
The experimental procedure has been reported elsewhere in detail [6, 7, 35]. In 
brief, after the rat was anaesthetised with pentobarbitone sodium, the right kidney was 
removed to measure renal noradrenaline content. Then, the abdominal aorta was 
isolated 1 cm proximally and distally to the left renal artery. All visible branches from 
the isolated aorta were ligated excepting the left renal artery and the mesenteric artery. 
The left ureter and the mesenteric artery were cannulated to allow urine collection and 
measurement of aortic pressure close to the left renal artery (i.e., renal arterial inflow 
pressure), respectively. A catheter connected to the perfusion set up was inserted in the 
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retrograde fashion through the abdominal aorta to a position distal to the left kidney. 
The aorta was tied off just above the mesenteric artery to make a closed arterial circuit 
including the left kidney, and the left renal vein was cut. Thereafter, perfusion of the left 
kidney was commenced with oxygenated Tyrode’s solution supplemented with 20 g・L-1 
dextran, 0.9 mmol・L-1 sodium nitroprusside, 10 mg・L-1 furosemide and 1 g・L-1 inulin. 
The rat was killed with overdose of pentobarbital sodium, and the renal capsule was 
removed. A needle (25 gauge, inner diameter 0.3 mm) was inserted perpendicular into 
the renal cortex for intrarenal tissue pressure measurement.  
Thirty minutes after initiating renal perfusion, collection of urine and 
measurements of arterial inflow pressure and intrarenal tissue pressure were repeated 
during 7 or 8 stepwise increments of perfusion flow from 2 to 9 mL/min. Urinary 
volumes were determined gravimetrically. Inulin concentrations in the perfusate and 
urine were measured, and glomerular filtration rate (GFR) was calculated as inulin 
clearance. After the final measurements, the perfusate was changed to a fixative 
containing 2% w/v formaldehyde and 0.5% w/v glutaraldehyde in 0.075 mol•L-1 
phosphate buffer (pH=7.2), with which the left kidney was perfused at a rate of 3 
mL•min-1 for 60 min. The perfusion of the fixative did not alter the perfusion pressure 
in this preparation, suggesting that there was no effect on the relaxed status of the 
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vasculature. The left kidney was then removed and placed in 7.4% w/v formaldehyde. 
The kidney was sliced into 2 mm thickness and every second slice was embedded in 
paraffin. One section from each block was cut at 2 µm thickness and stained with 
periodic acid-Schiff (PAS). At the end of experiment, the heart was dissected so that the 
left and right ventricle was weighed separately. 
Renal haemodynamics and histological appearance in the perfused kidneys  
In the maximally vasodilated, perfused kidneys, neurohumoral and active 
autoregulatory control systems are assumed to be inoperative; therefore, the analysis of 
haemodynamic behavior enables us to perform the following functional assessments of 
structural properties in the renal resistance vessels [6, 7, 35]. In the flow-pressure 
relationship, the gradient is the renal vascular resistance at maximal dilatation (i.e., 
minimal renal vascular resistance), which is an accurate index of averaged overall 
lumen dimensions of the preglomerular and postglomerular vasculature. In the 
pressure-GFR relationship, the intercept of the line with the pressure axis (i.e., the 
threshold pressure for commencing filtration) and the gradient of the line reflect 
preglomerular： postglomerular vascular resistance ratio and glomerular filtration 
capacity, respectively. 
To estimate the above-mentioned 3 functional parameters, the flow-pressure 
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and pressure-GFR relationships were established by the use of the perfusion flow, 
arterial distending pressure and GFR at each flow rate in the present study. In the 
relationships, arterial distending pressure (i.e., transmural pressure), calculated as 
arterial inflow pressure minus renal tissue pressure, was adopted as pressure, because 
tissue pressure built up during the perfusion, thereby inhibiting distension of the 
vasculature [6, 7, 35]. 
In renal morphological analysis, cross-sectional areas of the wall and lumen in 
the proximal interlobular arteries and glomerular tuft area were measured with a 
digitising tablet (SD-510C, Wacom Co) under light microscopy. The wall-to-lumen ratio 
(i.e., media：lumen ratio) was calculated by dividing the cross-sectional area of the wall 
by that of the lumen. The histological appearances of glomeruli were also evaluated. 
The measurements were performed randomly in 10 to 15 vessels, 30 to 40 superficial 
glomeruli and 20 to 30 juxtamedullary glomeruli per animal.  
Renal noradrenaline content 
Renal noradrenaline content was measured in the right kidney removed at the 
renal perfusion experiments, as follows [7]. The kidneys were homogenised with 2 mL 
of 0.4 % perchloric acid containing 0.1% w/v EDTA at 0°C. The homogenates were 
centrifuged at 6000 r.p.m for 15 min. The noradrenaline levels of supernatant fluids 
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were measured by high-performance liquid chromatography and electrochemical 
detection.  
Statistical analysis 
All data are expressed as mean ± SEM. Inflow volume and GFR are expressed 
as values divided by wet weight of the right kidney. The assumption that flow-pressure 
and pressure-GFR relationships were linear in all individual experiments was tested 
using the Pearson correlation coefficient in simple regression analysis. The slope and X 
intercept of these relationships were derived from the individual regression lines. 
Differences between the strains and differences between the treatments were determined 
using one-way analysis of variance (ANOVA). Comparisons of the effect of anti-NGF 
treatment between the 2 strains were tested by two-way ANOVA. Two-tailed P< 0.05 
was considered significant. 
Disclosure: The authors declared no conflict of interest.  
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Figure legends 
Figure 1 Relationships between inflow volume and arterial distending pressure in 
spontaneously hypertensive rats (SHR: d-f) and Wistar-Kyoto (WKY) rats (a-c). Results 
are shown as individual lines in rats treated with vehicle (a, d) or antiserum against 
nerve growth factor (anti-NGF) (b, e). Averaged lines of the relationship in rats treated 
with vehicle (dashed lines) or anti-NGF (solid lines) were also shown (c, f). In the rats 
treated with vehicle, the gradient of the flow-pressure relationship was significantly 
greater in SHR than in WKY (P< 0.001). The gradient of the line was less in SHR 
treated with anti-NGF compared with SHR treated with vehicle (P< 0.001), although it 
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did not differ significantly between WKY rats treated with anti-NGF and WKY rats 
treated with vehicle (P= 0.19) (P= 0.009 for strain × treatment interaction). As a result, 
the gradient of line did not differ significantly between SHR treated with anti-NGF and 
WKY treated with vehicle (P= 0.47). Differences between the strains and differences 
between the treatments were determined using one-way analysis of variance (ANOVA). 
Comparisons of the changes induced by anti-NGF between the 2 strains were tested by 
two-way ANOVA.  
Figure 2 Relationships between arterial distending pressure and glomerular filtration 
rate (GFR) in spontaneously hypertensive rats (SHR) (d-f) and Wistar-Kyoto (WKY) 
rats (a-c). Results are shown as individual lines in rats treated with vehicle (a, d) or 
antiserum against nerve growth factor (anti-NGF) (b, e). Averaged lines of the 
relationship in rats treated with vehicle (dashed lines) or anti-NGF (solid lines) were 
also shown (c, f). In the rats treated with vehicle, the X intercept of the pressure-GFR 
relationship was significantly higher in SHR than in WKY rats (P< 0.001), although the 
gradient of the line did not differ significantly between the two strains (P= 0.15). The 
gradient of the line was greater in SHR treated with anti-NGF than in SHR treated with 
vehicle (P= 0.003), although it did not differ significantly between WKY rats treated 
with anti-NGF and WKY rats treated with vehicle (P= 0.30) (P= 0.036 for strain × 
33 
 
treatment interaction). As a result, the gradient of the line was greater in SHR treated 
with anti-NGF than in WKY rats treated with vehicle (P= 0.004). Contrary, anti-NGF 
did not affect the X-intercept of the line in either strain. Differences between the strains 
and differences between the treatments were determined using one-way analysis of 
variance (ANOVA). Comparisons of the changes induced by anti-NGF between the 2 
strains were tested by two-way ANOVA. 
Figure 3 Morphological characteristics of preglomerular vessels in maximally 
vasodilated kidneys at 10 weeks of age in spontaneously hypertensive rats (SHR) and 
Wistar-Kyoto rats (WKY) treated with antiserum against nerve growth factor 
(anti-NGF) or vehicle at 3 weeks of age. (c) and (d) show interlobular artery of SHR 
treated with vehicle and anti-NGF, respectively. (a) and (b) show interlobular artery of 
WKY treated with vehicle and anti-NGF, respectively. See text for details. Original 
photography taken by ×400, each bar shows 50 μm. 
 
 
